US Stock MarketDetailed Quotes

Phathom Pharmaceuticals (PHAT)

Watchlist
  • 12.610
  • -0.180-1.41%
Close Apr 16 15:59 ET
1.00BMarket Cap-4.16P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Phathom Pharmaceuticals (PHAT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
37.48%-166.78M
92.12%-5M
77.80%-14.12M
11.30%-62.73M
-23.05%-84.93M
-93.90%-266.77M
-44.89%-63.46M
-99.20%-63.57M
-218.56%-70.72M
-73.99%-69.02M
Net income from continuing operations
33.82%-221.25M
71.59%-21.15M
64.98%-29.97M
17.10%-75.81M
-13.84%-94.32M
-65.84%-334.33M
6.43%-74.45M
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
Depreciation and amortization
-20.38%633K
-33.68%128K
-18.32%156K
-12.69%172K
-17.29%177K
38.26%795K
4.32%193K
57.85%191K
60.16%197K
46.58%214K
Other non cash items
-34.91%37.22M
-47.03%6.9M
-44.40%7.96M
-27.98%10.67M
-22.17%11.68M
78.36%57.18M
26.17%13.03M
91.44%14.32M
112.88%14.81M
105.94%15.01M
Change In working capital
19.10%-12.38M
144.78%4.05M
-212.42%-1.56M
-850.64%-5.95M
-26.96%-8.91M
-12.12%-15.3M
-1,436.69%-9.04M
157.42%1.39M
-114.13%-626K
57.03%-7.02M
-Change in receivables
-5.84%-39.33M
-25.89%-22.34M
55.44%-4.53M
-112.82%-14.89M
208.47%2.43M
-2,170.01%-37.16M
-984.00%-17.75M
---10.18M
---7M
---2.24M
-Change in inventory
-91.81%-11.78M
135.90%2M
194.50%395K
-790.30%-1.85M
-2,863.46%-12.33M
34.95%-6.14M
40.24%-5.58M
-276.58%-418K
--268K
---416K
-Change in prepaid assets
171.86%5.51M
63.91%-2.13M
168.21%1.39M
43.13%-1.56M
1,647.20%7.81M
4.90%-7.67M
-2,218.11%-5.89M
112.42%519K
-282.12%-2.75M
108.69%447K
-Change in payables and accrued expense
-3.59%34.23M
37.30%27.64M
-90.15%1.12M
39.96%12.33M
-41.51%-6.87M
429.71%35.5M
105.53%20.13M
116.15%11.42M
206.69%8.81M
56.84%-4.85M
-Change in other current assets
---1.22M
----
----
----
----
--0
--0
----
----
----
-Change in other working capital
26.86%222K
119.51%90K
50.00%66K
-42.22%26K
-11.11%40K
-9.79%175K
-12.77%41K
-8.33%44K
-8.16%45K
-10.00%45K
Cash from discontinued investing activities
Operating cash flow
37.48%-166.78M
92.12%-5M
77.80%-14.12M
11.30%-62.73M
-23.05%-84.93M
-93.90%-266.77M
-44.89%-63.46M
-99.20%-63.57M
-218.56%-70.72M
-73.99%-69.02M
Investing cash flow
Cash flow from continuing investing activities
-69.63%-229K
-1,640.00%-87K
38.64%-27K
-110.87%-97K
55.00%-18K
91.74%-135K
98.95%-5K
95.31%-44K
-666.67%-46K
81.31%-40K
Net PPE purchase and sale
-69.63%-229K
-1,640.00%-87K
38.64%-27K
-110.87%-97K
55.00%-18K
91.74%-135K
98.95%-5K
95.31%-44K
-666.67%-46K
81.31%-40K
Cash from discontinued investing activities
Investing cash flow
-69.63%-229K
-1,640.00%-87K
38.64%-27K
-110.87%-97K
55.00%-18K
91.74%-135K
98.95%-5K
95.31%-44K
-666.67%-46K
81.31%-40K
Financing cash flow
Cash flow from continuing financing activities
-100.16%-288K
-100.37%-97K
-100.22%-271K
-99.68%80K
0
-50.28%182.77M
-87.71%26.05M
938,800.00%122.06M
-82.49%24.77M
-29.65%9.9M
Net issuance payments of debt
--0
--0
--0
--0
--0
51.08%59.4M
-37.05%24.75M
--0
--24.75M
--9.9M
Net common stock issuance
--0
--0
----
----
----
-21.67%121.78M
--0
--121.78M
--0
--0
Proceeds from stock option exercised by employees
2.44%1.64M
-2.39%1.27M
3.90%293K
----
----
1,189.52%1.6M
--1.3M
2,069.23%282K
----
----
Net other financing activities
---1.93M
---1.36M
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-100.16%-288K
-100.37%-97K
-100.22%-271K
-99.68%80K
--0
-50.28%182.77M
-87.71%26.05M
938,800.00%122.06M
-82.49%24.77M
-29.65%9.9M
Net cash flow
Beginning cash position
-21.89%300.13M
-59.11%138.02M
-45.38%152.43M
-33.81%215.18M
-21.89%300.13M
146.49%384.26M
55.88%337.54M
11.92%279.1M
149.92%325.1M
146.49%384.26M
Current changes in cash
-98.85%-167.29M
86.14%-5.19M
-124.66%-14.41M
-36.42%-62.75M
-43.59%-84.95M
-136.84%-84.13M
-122.31%-37.42M
277.95%58.44M
-138.56%-46M
-129.20%-59.16M
End cash Position
-55.74%132.83M
-55.74%132.83M
-59.11%138.02M
-45.38%152.43M
-33.81%215.18M
-21.89%300.13M
-21.89%300.13M
55.88%337.54M
11.92%279.1M
149.92%325.1M
Free cash flow
37.43%-167M
91.98%-5.09M
77.77%-14.14M
11.22%-62.83M
-23.01%-84.95M
-91.72%-266.91M
-43.34%-63.46M
-93.64%-63.62M
-218.68%-70.77M
-73.16%-69.06M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 37.48%-166.78M92.12%-5M77.80%-14.12M11.30%-62.73M-23.05%-84.93M-93.90%-266.77M-44.89%-63.46M-99.20%-63.57M-218.56%-70.72M-73.99%-69.02M
Net income from continuing operations 33.82%-221.25M71.59%-21.15M64.98%-29.97M17.10%-75.81M-13.84%-94.32M-65.84%-334.33M6.43%-74.45M-97.90%-85.58M-123.23%-91.45M-119.10%-82.85M
Depreciation and amortization -20.38%633K-33.68%128K-18.32%156K-12.69%172K-17.29%177K38.26%795K4.32%193K57.85%191K60.16%197K46.58%214K
Other non cash items -34.91%37.22M-47.03%6.9M-44.40%7.96M-27.98%10.67M-22.17%11.68M78.36%57.18M26.17%13.03M91.44%14.32M112.88%14.81M105.94%15.01M
Change In working capital 19.10%-12.38M144.78%4.05M-212.42%-1.56M-850.64%-5.95M-26.96%-8.91M-12.12%-15.3M-1,436.69%-9.04M157.42%1.39M-114.13%-626K57.03%-7.02M
-Change in receivables -5.84%-39.33M-25.89%-22.34M55.44%-4.53M-112.82%-14.89M208.47%2.43M-2,170.01%-37.16M-984.00%-17.75M---10.18M---7M---2.24M
-Change in inventory -91.81%-11.78M135.90%2M194.50%395K-790.30%-1.85M-2,863.46%-12.33M34.95%-6.14M40.24%-5.58M-276.58%-418K--268K---416K
-Change in prepaid assets 171.86%5.51M63.91%-2.13M168.21%1.39M43.13%-1.56M1,647.20%7.81M4.90%-7.67M-2,218.11%-5.89M112.42%519K-282.12%-2.75M108.69%447K
-Change in payables and accrued expense -3.59%34.23M37.30%27.64M-90.15%1.12M39.96%12.33M-41.51%-6.87M429.71%35.5M105.53%20.13M116.15%11.42M206.69%8.81M56.84%-4.85M
-Change in other current assets ---1.22M------------------0--0------------
-Change in other working capital 26.86%222K119.51%90K50.00%66K-42.22%26K-11.11%40K-9.79%175K-12.77%41K-8.33%44K-8.16%45K-10.00%45K
Cash from discontinued investing activities
Operating cash flow 37.48%-166.78M92.12%-5M77.80%-14.12M11.30%-62.73M-23.05%-84.93M-93.90%-266.77M-44.89%-63.46M-99.20%-63.57M-218.56%-70.72M-73.99%-69.02M
Investing cash flow
Cash flow from continuing investing activities -69.63%-229K-1,640.00%-87K38.64%-27K-110.87%-97K55.00%-18K91.74%-135K98.95%-5K95.31%-44K-666.67%-46K81.31%-40K
Net PPE purchase and sale -69.63%-229K-1,640.00%-87K38.64%-27K-110.87%-97K55.00%-18K91.74%-135K98.95%-5K95.31%-44K-666.67%-46K81.31%-40K
Cash from discontinued investing activities
Investing cash flow -69.63%-229K-1,640.00%-87K38.64%-27K-110.87%-97K55.00%-18K91.74%-135K98.95%-5K95.31%-44K-666.67%-46K81.31%-40K
Financing cash flow
Cash flow from continuing financing activities -100.16%-288K-100.37%-97K-100.22%-271K-99.68%80K0-50.28%182.77M-87.71%26.05M938,800.00%122.06M-82.49%24.77M-29.65%9.9M
Net issuance payments of debt --0--0--0--0--051.08%59.4M-37.05%24.75M--0--24.75M--9.9M
Net common stock issuance --0--0-------------21.67%121.78M--0--121.78M--0--0
Proceeds from stock option exercised by employees 2.44%1.64M-2.39%1.27M3.90%293K--------1,189.52%1.6M--1.3M2,069.23%282K--------
Net other financing activities ---1.93M---1.36M--------------------------------
Cash from discontinued financing activities
Financing cash flow -100.16%-288K-100.37%-97K-100.22%-271K-99.68%80K--0-50.28%182.77M-87.71%26.05M938,800.00%122.06M-82.49%24.77M-29.65%9.9M
Net cash flow
Beginning cash position -21.89%300.13M-59.11%138.02M-45.38%152.43M-33.81%215.18M-21.89%300.13M146.49%384.26M55.88%337.54M11.92%279.1M149.92%325.1M146.49%384.26M
Current changes in cash -98.85%-167.29M86.14%-5.19M-124.66%-14.41M-36.42%-62.75M-43.59%-84.95M-136.84%-84.13M-122.31%-37.42M277.95%58.44M-138.56%-46M-129.20%-59.16M
End cash Position -55.74%132.83M-55.74%132.83M-59.11%138.02M-45.38%152.43M-33.81%215.18M-21.89%300.13M-21.89%300.13M55.88%337.54M11.92%279.1M149.92%325.1M
Free cash flow 37.43%-167M91.98%-5.09M77.77%-14.14M11.22%-62.83M-23.01%-84.95M-91.72%-266.91M-43.34%-63.46M-93.64%-63.62M-218.68%-70.77M-73.16%-69.06M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -